With Pfizer, Moderna, and Astrozeneca Covid-19 vaccine trials showing promise, the U.S. needs a way to inoculate enough of its population to achieve herd immunity. Paying Americans $1,000 to get the vaccine could be a simple, yet effective proposal.
Today’s “silver tsunami” looks quite different from the one predicted 10 years ago. As more and more older adults fall into homelessness, there are few societal safeguards for them.
Reduced demand for lucrative elective procedures is forcing hospital systems to merge or partner up to augment other services that have boomed during the pandemic.
Reduced demand for lucrative elective procedures is forcing hospital systems to merge or partner up to augment other services that have boomed during the pandemic.